#hepatitis C treatment

People with hepatocellular carcinoma had improved survival after the advent of direct-acting antiviral therapy.

However, people with liver cirrhosis remain at risk and should continue screening even after being cured.

Left untreated, hepatitis C can lead to cirrhosis, liver cancer and the need for a liver transplant.

Liver cancer is now less likely to be caused by hepatitis B or C, but more likely to be caused by fatty liver disease or alcohol.

People who developed hepatocellular carcinoma after being cured of HCV had cirrhosis and worse liver function.

Universal HCV testing led to an increase in the number of pregnant women and infants diagnosed in a timely manner.

Men and Black people were more likely to have antibodies against hepatitis C virus.

Hepatocellular carcinoma can still occur after hepatitis C is cured, and risk factors differ for people with and without cirrhosis.

The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.

People treated with direct-acting antivirals had better overall survival than those whose hepatitis C remained untreated.

Despite limited testing and clinical visits, 95% of the study population was able to achieve a sustained virological response.

Hepatitis A and E usually resolve on their own, but hepatitis B and C can cause serious liver disease, including cirrhosis and liver cancer.

Requiring sobriety prior to treatment and curtailing harm reduction hinder efforts to eliminate hep C.

The blood-borne virus, which can lead to cirrhosis and liver cancer, remains a major global health threat.

Homeless people, incarcerated individuals and people with mental health conditions achieved a high cure rate.

All people ages 18 to 79 should be screened for hepatitis C virus at least once, regardless of risk factors.